Acadia Pharmaceuticals Inc.
$4.96B- Market cap
- $4.83B
- Debt
- +$306.51M
- Cash
- −$177.70M
Capital structure 94% equity / 6% debt · EV / Revenue 4.63x · EV / EBITDA 32.92x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
ACAD · current priceP/E 12.19x
$28.04Latest market snapshot
Implied fair value · at SMCI's multiple
$27.950.3% below market
2.30 ACAD EPS (TTM)×12.15x SMCI P/E=$27.95
Market $28.04Implied $27.95
SMCI · current priceP/E 12.15x
$39.61Latest market snapshot
Implied fair value · at ACAD's multiple
$39.740.3% above market
3.26 SMCI EPS (TTM)×12.19x ACAD P/E=$39.74
Market $39.61Implied $39.74